EP1401858A4 - Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation - Google Patents

Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation

Info

Publication number
EP1401858A4
EP1401858A4 EP02739617A EP02739617A EP1401858A4 EP 1401858 A4 EP1401858 A4 EP 1401858A4 EP 02739617 A EP02739617 A EP 02739617A EP 02739617 A EP02739617 A EP 02739617A EP 1401858 A4 EP1401858 A4 EP 1401858A4
Authority
EP
European Patent Office
Prior art keywords
methods
nucleic acids
acids encoding
encoding same
therapeutic polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02739617A
Other languages
German (de)
English (en)
Other versions
EP1401858A2 (fr
Inventor
David W Anderson
Jason C Baumgartner
Ferenc L Boldog
Stacie J Casman
Schlomit R Edinger
Esha A Gangolli
Valerie L Gerlach
Linda Gorman
Xiaojia Guo
Tord Hjalt
Ramesh Kekuda
Li Li
John R Macdougall
Uriel M Malyankar
Isabelle Millet
Muralidhara Padigaru
Meera Patturajan
Carol E A Pena
Luca Rastelli
Richard A Shimkets
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/162,335 external-priority patent/US7034132B2/en
Application filed by CuraGen Corp filed Critical CuraGen Corp
Publication of EP1401858A2 publication Critical patent/EP1401858A2/fr
Publication of EP1401858A4 publication Critical patent/EP1401858A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP02739617A 2001-06-04 2002-06-04 Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation Withdrawn EP1401858A4 (fr)

Applications Claiming Priority (39)

Application Number Priority Date Filing Date Title
US261189P 2001-01-16
US29560701P 2001-06-04 2001-06-04
US29566101P 2001-06-04 2001-06-04
US295661P 2001-06-04
US295607P 2001-06-04
US29641801P 2001-06-06 2001-06-06
US29640401P 2001-06-06 2001-06-06
US295404P 2001-06-06
US296418P 2001-06-06
US29828501P 2001-06-14 2001-06-14
US298285P 2001-06-14
US29855601P 2001-06-15 2001-06-15
US298556P 2001-06-15
US29994901P 2001-06-21 2001-06-21
US299949P 2001-06-21
US30088301P 2001-06-26 2001-06-26
US300883P 2001-06-26
US30155001P 2001-06-28 2001-06-28
US301550P 2001-06-28
US31197201P 2001-08-13 2001-08-13
US311972P 2001-08-13
US31507101P 2001-08-27 2001-08-27
US315071P 2001-08-27
US31566001P 2001-08-29 2001-08-29
US315660P 2001-08-29
US32229301P 2001-09-14 2001-09-14
US322293P 2001-09-14
US32270601P 2001-09-17 2001-09-17
US322706P 2001-09-17
US34118601P 2001-12-14 2001-12-14
US341186P 2001-12-14
US36118902P 2002-02-28 2002-02-28
US36367602P 2002-03-12 2002-03-12
US36367302P 2002-03-12 2002-03-12
US363673P 2002-03-12
US363676P 2002-03-12
US162335 2002-06-03
US10/162,335 US7034132B2 (en) 2001-06-04 2002-06-03 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
PCT/US2002/017428 WO2002099116A2 (fr) 2001-06-04 2002-06-04 Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation

Publications (2)

Publication Number Publication Date
EP1401858A2 EP1401858A2 (fr) 2004-03-31
EP1401858A4 true EP1401858A4 (fr) 2005-12-21

Family

ID=28047119

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02739617A Withdrawn EP1401858A4 (fr) 2001-06-04 2002-06-04 Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation

Country Status (3)

Country Link
EP (1) EP1401858A4 (fr)
CA (1) CA2448073A1 (fr)
WO (1) WO2002099116A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6815181B2 (en) * 2001-07-09 2004-11-09 Applera Corporation Nucleic acid molecules encoding human secreted hemopexin-related proteins
EP2248899B8 (fr) 2003-03-19 2015-07-15 Biogen MA Inc. Protéine de liaison du récepteur NOGO
WO2006002437A2 (fr) 2004-06-24 2006-01-05 Biogen Idec Ma Inc. Traitement d'etats pathologiques impliquant la demyelinisation
AU2006269458B2 (en) 2005-07-08 2012-11-08 Biogen Ma Inc. Sp35 antibodies and uses thereof
EP1992694A1 (fr) * 2007-05-16 2008-11-19 Gene Signal International Sa Médicament anti-tumoral, médicament, composition et leurs utilisations
ES2674710T3 (es) 2007-05-16 2018-07-03 Gene Signal International Sa Fármaco, medicamento, composición antitumoral y uso de los mismos
JP2011527572A (ja) 2008-07-09 2011-11-04 バイオジェン・アイデック・エムエイ・インコーポレイテッド Ｌｉｎｇｏ抗体または断片を含む組成物
US9796780B2 (en) 2012-05-14 2017-10-24 Biogen Ma Inc. LINGO-2 antagonists for treatment of conditions involving motor neurons
EP3242893A1 (fr) 2015-01-08 2017-11-15 Biogen MA Inc. Antagonistes de lingo-1 et leurs utilisations pour le traitement de troubles de démyélinisation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0198645A1 (fr) * 1985-04-05 1986-10-22 Sankyo Company Limited Elastase pancréatique humaine
WO2001023419A2 (fr) * 1999-09-27 2001-04-05 Scios Inc. Facteurs secretes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5951221A (ja) * 1982-09-17 1984-03-24 Eisai Co Ltd 変形性関節症治療剤
US4643991A (en) * 1984-12-18 1987-02-17 The University Of Kentucky Research Foundation Peptide elastase inhibitors and methods
US5212068A (en) * 1985-04-05 1993-05-18 Sankyo Company Limited Human pancreatic elastase
JPH0673456B2 (ja) * 1986-04-26 1994-09-21 三共株式会社 ヒト・膵臓エラスタ−ゼ▲ｉ▼
US4746729A (en) * 1986-07-30 1988-05-24 Kuettner Klaus E Cartilage-derived leukocyte elastase-inhibitor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0198645A1 (fr) * 1985-04-05 1986-10-22 Sankyo Company Limited Elastase pancréatique humaine
WO2001023419A2 (fr) * 1999-09-27 2001-04-05 Scios Inc. Facteurs secretes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 19 April 1991 (1991-04-19), "cDNA sequence coding for human pancreas elastase-2.", XP002331953, retrieved from EBI accession no. AAN71123 *
KAWASHIMA I ET AL: "Characterization of pancreatic elastase II cDNAs: two elastase II mRNAs are expressed in human pancreas.", DNA (MARY ANN LIEBERT, INC.) APR 1987, vol. 6, no. 2, April 1987 (1987-04-01), pages 163 - 172, XP008048458, ISSN: 0198-0238 *

Also Published As

Publication number Publication date
WO2002099116A2 (fr) 2002-12-12
WO2002099116A3 (fr) 2003-11-20
EP1401858A2 (fr) 2004-03-31
WO2002099116A8 (fr) 2003-09-25
CA2448073A1 (fr) 2002-12-12

Similar Documents

Publication Publication Date Title
WO2003023008A8 (fr) Polypeptides therapeutiques, acides nucleiques les codant, et modalites d'emploi correspondantes
EP1576169A4 (fr) Polypeptides therapeutiques, acides nucleiques codant pour ceux-ci et methodes d'utilisation associees
EP1487864A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation associees
AU2002356534A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU9633301A (en) Paad domain-containing polypeptides, encoding nucleic acids, and methods of use
EP1446419A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ceux-ci et procedes d'utilisation
EP1432726A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ces derniers et methodes d'utilisation correspondantes
EP1401858A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation
AU2003217956A8 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
EP1532238A4 (fr) Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant
EP1539985A4 (fr) Polypeptides therapeutiques, acides nucleiques encodant ces polypeptides, et procedes d'utilisation
EP1443913A4 (fr) Polypeptides therapeutiques, acides nucleiques encodant ces polypeptides et leurs procedes d'utilisation
EP1399537A4 (fr) Polypeptides therapeutiques, acides nucleiques les codant, et procedes d'utilisation
EP1695078A4 (fr) Polypeptides de metadherine codant des acides nucleiques et procedes d'utilisation
EP1549671A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation associees
EP1383533A4 (fr) Proteines et acides nucleiques codant pour celles-ci
AU2002309646A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2002365216A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003304034A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU4157002A (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2003270424A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003060149A9 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation
EP1504026A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ceux-ci et procedes d'utilisation
AU2002360485A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1513864A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ces derniers et leurs procedes d'utilisation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20031229

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12N 15/12 B

Ipc: 7C 07K 14/47 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

A4 Supplementary search report drawn up and despatched

Effective date: 20051108

18W Application withdrawn

Effective date: 20051102